GeneCentric secures $8m to launch liquid biopsy platform
GeneCentric Therapeutics has secured $8m in a Series C funding round for its comprehensive liquid biopsy testing system, GenomicsNext. The post GeneCentric secures $8m to launch liquid biopsy platform appeared first on Medical Device Network.

The post GeneCentric secures $8m to launch liquid biopsy platform appeared first on Medical Device Network.